Lei Yuan
- Cancer Research top 5%
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Protease and Inhibitor Mechanisms 5
-
- Cardiac electrophysiology and arrhythmias 11
- Molecular Biology top 10%
- RNA modifications and cancer 9
- Ion channel regulation and function 6
- Natural product bioactivities and synthesis 5
- Animal Science and Zoology top 5%
- Oncology top 10%
- Peptidase Inhibition and Analysis 7
- Journals
- Science (1 paper)SHILAP Revista de lepidopterología (1 paper)Nature Reviews Molecular Cell Biology (1 paper)
- Partner nations
- ChinaDenmarkUnited States
In The Last Decade
Lei Yuan
93 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 131
- Cancer Research 556
- Cardiology and Cardiovascular Medicine 445
- Molecular Biology 1.3k
- Animal Science and Zoology 152
- Oncology 364
Countries citing papers authored by Lei Yuan
This map shows the geographic impact of Lei Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Yuan more than expected).
Fields of papers citing papers by Lei Yuan
This network shows the impact of papers produced by Lei Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Yuan. The network helps show where Lei Yuan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 23 | |
| 7 | 2024 | 4 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 2 | |
| 11 | 2020 | 159 | |
| 12 | Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma | 2020 | 1 |
| 13 | 2020 | 32 | |
| 14 | 2020 | 13 | |
| 15 | 2018 | 24 | |
| 16 | 2018 | 35 | |
| 17 | 2018 | 45 | |
| 18 | 2018 | 72 | |
| 19 | 2014 | 157 | |
| 20 | 2008 | 36 |
About Lei Yuan
Lei Yuan is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 102 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (11 papers), RNA modifications and cancer (9 papers), Peptidase Inhibition and Analysis (7 papers), Ion channel regulation and function (6 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), Protease and Inhibitor Mechanisms (5 papers) and Natural product bioactivities and synthesis (5 papers). The work is most often cited by research in Cancer Research (556 citations), Cardiology and Cardiovascular Medicine (445 citations) and Molecular Biology (1.3k citations). Lei Yuan has collaborated with scholars based in China, Denmark and United States. Frequent co-authors include Na Liu, Thomas Jespersen, Yaqin Wang, Zhigang Song, Hongchao Jiao, Ying‐Qin Li, Jun Ma, Qing‐Mei He, Panpan Zhang and Hai Lin. Their work appears in journals such as Science, SHILAP Revista de lepidopterología and Nature Reviews Molecular Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.